Mylan N.V. Stock Price and Value Analysis

Should you buy Mylan N.V. stock? (NasdaqGS:MYL). Let's see how it does in our automated value investing analysis system.

AdvantagesDisadvantagesNeutral
  • This company has amazingly consistent growth!
  • This company is very stable.
  • This company is not making money.
  • This stock looks overpriced.
  • This company pays no dividend.

MYL Free Cash Flow Trend

Hmm, we can't give any reliable projection for Mylan N.V.'s growth rate. The company either has too few years of historical data for us to examine, or it's in the habit of losing money.

None of this means it's a bad stock. Maybe it's new and growing quickly, or maybe it's turning things around. We can't say anything sensible about it, so we won't say it's obviously undervalued right now. Proceed at your own risk!

Free Cash Flow trendline for MYL
Free Cash Flow trendline for Mylan N.V.

Inside the MYL Numbers

MYL Price
(Mylan N.V. stock price per share)
$26.85
[?] PE Ratio versus Sector 110% higher than other Healthcare stocks
[?] PE Ratio versus Industry 14% lower than other Drug Manufacturers - Specialty & Generic stocks
[?] Cash Yield 2.10%
[?] Free Cash Flow Jitter 0%

Is Mylan N.V. Stock on Sale?

Based on our analysis, we believe that you should not buy Mylan N.V. right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy MYL Stock?

Does Mylan N.V. have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.